Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04471493 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pediatric and Ambulatory Research in Infectious Diseases

Study acronym: PARI
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jun 27, 2024 to Jun 27, 2030
    • Study completion date: Aug 2, 2024 to Aug 2, 2030
    v6
  2. Primary completion date: Jun 27, 2023 to Jun 27, 2024
    • Study completion date: Aug 2, 2023 to Aug 2, 2024
    v5
  3. Re-verified, no change to tracked fieldsv4
  4. Primary completion date: Feb 27, 2022 to Jun 27, 2023
    • Study completion date: Mar 2, 2022 to Aug 2, 2023
    v3
  5. Collaborators: 1 to 5v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Many ambulatory networks are mainly based on diagnoses made by first-line physicians not specifically trained to join the network. Here we aim to set up a surveillance network on pediatric infectious diseases with an investment in teaching with specific trainings of participating pediatricians, increasing in use of point of care tests, and automated data extraction from the computers of the pediatricians.
Trial Details
NCT Number NCT04471493
Lead Sponsor Association Clinique Thérapeutique Infantile du val de Marne
Collaborators: AFPA (Association Française de Pédiatrie Ambulatoire), GlaxoSmithKline, Sanofi, Pfizer, Merck Sharp & Dohme LLC
Conditions
(from sponsor)		 Otitis, Bronchiolitis, Influenza, Pharyngitis, Varicella, Pneumonia, Gastroenteritis
Related terms Bronchiolitis, Chickenpox, Gastroenteritis, Influenza, Human, Otitis, Pharyngitis, Pneumonia
Enrollment 400,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov